Team Sanford-Burnham happy hour success
On July 24, Bella Vista Social Club & Caffe hosted a special happy hour in support of Team Sanford-Burnham and Pedal the Cause. 15 percent of all proceeds raised from the happy hour went directly to help Team Sanford-Burnham reach their 2014 fundraising goal.
The event was a great success that brought together Team Sanford-Burnham riders, Pedal the Cause volunteers and supporters, as well as other individuals interested in signing up to ride in the upcoming Pedal the Cause event on September 20-21.
Over 25 attendees from throughout San Diego came out to enjoy the gorgeous view of the Pacific Ocean, sample delicious nibbles, and sip refreshing cocktails— all while showing their support to our dedicated team of riders.
Thank you to Bella Vista Social Club & Caffe—and to all those who joined us during the happy hour for your gracious support!
If you are interested in attending the next Team Sanford-Burnham happy hour, please contact James Short at firstname.lastname@example.org
If you would like more information on how you can get involved, please visit Pedal the Cause’s website.
About Pedal the Cause
Founded in 2012, Pedal The Cause—San Diego is a California nonprofit public benefit corporation established to fund, plan, and manage an annual cycling fundraiser in which 100 percent of the proceeds stay in San Diego to benefit cancer research at the three National Cancer Institute-designated cancer centers. The hope is that research funded by Pedal The Cause will ultimately lead to a cure for cancer, and propel San Diego to the forefront of cancer cures and care. For more information, please visit pedalthecause.org, or go to facebook.com/pedalthecause and Twitter @pedalthecause.
About the C3
The mission of the C3 is to encourage interactions between the San Diego National Cancer Institute (NCI)-designated centers, with a special focus on clinical, translational, basic science, and educational activities. Each San Diego institute will share its unique capabilities and talents. Sanford-Burnham will provide access to its Chemical Library Screening Core, enabling Salk and UC San Diego to use the extensive chemical biology and drug development resources of the Prebys Center. The Prebys Center provides assay development and robust, sensitive high-throughput assays. The Center helps identify chemical compounds that lead to drug candidates that may be further developed into cancer therapies. The Salk Institute’s Cancer Center Gene Transfer, Targeting, and Therapeutics Core (GT3) will offer design, consultation, and production services for viral vectors. Viral vectors are “biological vehicles” that deliver new genes to cells to alter their function, potentially “fixing” cells that are malfunctioning. Viral vectors may be used to replace faulty genes in cancer cells, or used to boost cell functions that protect against cancer. The UC San Diego Biorepository Core will provide access to its centralized resource for patient samples and clinical information. Allowing researchers access to human samples is essential to discovering biological targets to treat cancer, translating experimental results to human disease, and for developing cancer diagnostic tests. By sharing knowledge and valuable resources, the C3 institutes are creating an era of inter-institutional support and cooperation to accelerate the prevention, diagnosis, and treatment of cancer.